FDA Bans CFC Inhalers, Walmart Offers Low-Cost Alternative
An FDA mandate that came into effect on Dec. 31 dictates that all albuterol metered-dose asthma inhalers marketed in the U.S. must use hydrofluroalkane (HFA) propellants, as opposed to chlorofluorocarbon (CFC) propellants.
Most manufacturers, like GlaxoSmithKline (GSK) and Schering-Plough, hurried to make the transition and have increased production to ensure an adequate supply of HFA inhalers. Armstrong Pharmaceuticals has not yet done so, the FDA said.
Rescue inhalers can be costly: some HFA inhalers may sell for as much as $60 for certain brands. To make the life-saving medication affordable, Walmart is going to sell the ReliOn Ventolin HFA inhaler for $9.
Energy Manager News
- Switching to LEDs Without Leaving the Past Behind
- McKinstry Replacing 6,200 Lights with LEDs in Henderson, NV
- USDA Investing More than $300M in Efficiency, Renewables
- ERC Price Benchmark Trends Week Ending: October 21, 2016
- Could Cleaner Energy Save Ohio Ratepayers $50M in 2030, Alone?
- Yakima City Council Mulls Utility Rate Hike on Large Businesses to Bolster Reserve Fund
- Making Solar Inverters Smarter
- Unlocking the Power of Building Data